Home Newsfeeds SVB Leerink Maintains Outperform on NeoGenomics, Raises Price Target to $15

SVB Leerink Maintains Outperform on NeoGenomics, Raises Price Target to $15

SVB Leerink analyst Puneet Souda maintains NeoGenomics (NASDAQ:NEO) with a Outperform and raises the price target from $12 to $15.

byBenzinga Newsdesk

November 9, 2022

1 minute read

SVB Leerink analyst Puneet Souda maintains NeoGenomics (NASDAQ:NEO) with a Outperform and raises the price target from $12 to $15.

Amazon’s Newark Airport Deal Succumbs To Unionization

By Anusuya Lahiri

July 8, 7:50 AM

Amazon.com, Inc (NASDAQ:AMZN) and the Port Authority of New York and New Jersey ended talks for a potential deal to develop…

AMZN

BP, Chegg, Arista Networks And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

By Lisa Levin

May 2, 6:23 AM

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

ANET

Valneva Announces Launch Of Approximately $40 Million In Proposed Global Offering Of American Depositary Shares, Ordinary Shares

By Michael Horton

September 28, 5:47 PM

Valneva SE (NASDAQ:VALN, PARIS:VLA) (the "Company"), a specialty vaccine company, today announced its intention to issue and sell, subject to market conditions, approximately $40 million of its

PARIS:VLA

Analyst Ratings

4 Analysts Have This to Say About 2U

By Benzinga Insights

November 10, 1:00 PM

2U (NASDAQ:TWOU) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

TWOU

SVB Leerink Maintains Outperform on NeoGenomics, Raises Price Target to $15

Related Posts

Amazon’s Newark Airport Deal Succumbs To Unionization

BP, Chegg, Arista Networks And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

Valneva Announces Launch Of Approximately $40 Million In Proposed Global Offering Of American Depositary Shares, Ordinary Shares

4 Analysts Have This to Say About 2U